Meet Dr. Peter Attia
Peter Attia, MD
Founder of Early Medical
Dr. Peter Attia is a renowned physician who specializes in longevity and healthspan. He is the founder of Early Medical, a practice that utilizes the principles of Medicine 3.0 to enhance patients' lifespans and healthspans.
A Stanford University School of Medicine graduate, Dr. Attia has trained at the Johns Hopkins Hospital and the National Institutes of Health. He is also the host of the popular podcast The Drive and author of the #1 New York Times Bestseller Outlive: The Science and Art of Longevity.
Areas of Expertise
Primary Expertise
Longevity and Medicine 3.0
Research Interests
Longevity, healthspan, immune-based therapies for cancer, and preventative medicine.
Academic Credentials
Medical Degree: Stanford University School of Medicine
Surgical Training: General Surgery, Johns Hopkins Hospital
Fellowship: Surgical Oncology, National Cancer Institute, National Institutes of Health
Professional Affiliations
Founder, Early Medical
Host, The Drive Podcast
PROFESSIONAL JOURNEY
Dr. Attia is the founder of Early Medical, a practice focused on extending lifespan and healthspan through personalized and preventive medical care. He hosts The Drive podcast, where he engages with experts on topics related to health, medicine, and longevity. He is also the author of the #1 New York Times Bestseller, Outlive: The Science and Art of Longevity, which offers evidence-based strategies for achieving a longer, healthier life.
Major Contributions
Innovations in Applying Medicine 3.0 Principles
Dr. Peter Attia has pioneered the application of Medicine 3.0 principles to clinical practice, focusing on proactive, data-driven strategies to optimize patient health and prevent age-related diseases. His approach integrates advanced diagnostics and personalized care plans to enhance both lifespan and healthspan, shifting the focus from reactive treatment to preventive medicine.
Research on Immune-Based Therapies for Melanoma
Dr. Attia conducted research on immune-based therapies for melanoma, exploring how the body's own immune system can be harnessed to fight cancer. His work contributed to understanding the potential of immunotherapy in treating melanoma, paving the way for new approaches to cancer treatment.
Detailed Information on Dr. Peter Attia
Research Techniques
Longevity studies
Healthspan analysis
Immune-based therapy research
Preventive medicine approaches
Notable Works
Books:
Reiter, R. J., & Robinson, J. (1996). Melatonin. National Geographic Books.
Fraschini, F., & Reiter, R. J. (2012). Role of Melatonin and Pineal Peptides in Neuroimmunomodulation. Springer Science & Business Media.
Publications:
- Reiter, R. J., Tan, D. X., & Galano, A. (2014). Melatonin: exceeding expectations.Physiology (Bethesda, Md.),29(5), 325–333. https://doi.org/10.1152/physiol.00011.2014
- Reiter R. J. (2003). Melatonin: clinical relevance.Best practice & research. Clinical endocrinology & metabolism,17(2), 273–285. https://doi.org/10.1016/s1521-690x(03)00016-2
- Reiter, R. J., Rosales-Corral, S. A., Tan, D. X., Acuna-Castroviejo, D., Qin, L., Yang, S. F., & Xu, K. (2017). Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.International journal of molecular sciences,18(4), 843. https://doi.org/10.3390/ijms18040843
- Reiter, R. J., Sharma, R., Simko, F., Dominguez-Rodriguez, A., Tesarik, J., Neel, R. L., Slominski, A. T., Kleszczynski, K., Martin-Gimenez, V. M., Manucha, W., & Cardinali, D. P. (2022). Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection.Cellular and molecular life sciences : CMLS,79(3), 143. https://doi.org/10.1007/s00018-021-04102-3
- Reiter, R. J., Abreu-Gonzalez, P., Marik, P. E., & Dominguez-Rodriguez, A. (2020). Therapeutic Algorithm for Use of Melatonin in Patients With COVID-19.Frontiers in medicine,7, 226. https://doi.org/10.3389/fmed.2020.00226
Contact Information
Professional Contact: reiter@uthscsa.edu
Office Address: UT Health San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229
Phone: 210-567-3859